Taevas
AustraliaMedical Devices
Legal Representation
Legal Representation for Medical Devices in Australia
Taevas Global acts as your Australian Sponsor under TGA regulations, enabling overseas medical device manufacturers to register, market, and distribute products in Australia without establishing a local entity. We bridge the compliance gap so you can focu
Market
Australia
Industry
Medical Devices
Service
Legal Representation
Regulator
Therapeutic Goods Administration (TGA)
Timeline
6-12 weeks to ARTG inclusion
What We Deliver
Six Pillars of Australia Market Entry
Our Legal Representation service for Medical Devices in Australia is built on six interconnected pillars that cover every obligation from initial TGA engagement through ongoing post-market vigilance.
01
Australian Sponsor Appointment
Under the Therapeutic Goods Act 1989, every medical device supplied in Australia must have an Australian Sponsor who holds legal responsibility for the product. Taevas Global formally accepts Sponsor obligations on your behalf, allowing overseas manufacturers to access the Australian market without a local subsidiary. We execute the Sponsor appointment deed and maintain all required documentation with the TGA.
Formal Sponsor deed execution and TGA notification
Ongoing maintenance of Sponsor records and contact details
Transfer-of-sponsorship management if you later establish a local entity
How It Works
From Brief to Market-Ready Status
Our four-step engagement takes you from initial scoping through to active ARTG inclusion and ongoing compliance support, with clear milestones and dedicated regulatory advisors at every stage.
Step 1 · Day 1-3
Scoping and Regulatory Assessment
We begin with a structured intake session to understand your device portfolio, existing certifications, target markets within Australia, and commercial timeline. Our regulatory team conducts an initial classification review and identifies the applicable ARTG pathway, conformity assessment requirements, and any unique Australian-specific obligations for your device class.
Taevas Approach
You receive a written Regulatory Assessment Report that maps your device against TGA classification rules, identifies required conformity assessment certificates, lists documentation gaps, and provides a realistic timeline and cost estimate for ARTG inclusion. This report forms the foundation of your Australian market entry plan.
Market Snapshot
Australia Medical Devices Market at a Glance
A$0B
Medical Devices Market Size (2024 est.)
0%
Projected Annual Market Growth Rate
0K+
Active ARTG Device Inclusions
0+
Licensed Medical Device Sponsors
TGA Regulatory Alignment with International Standards
Australia's TGA has progressively aligned its medical device framework with the European MDR and ISO 13485, making it relatively accessible for manufacturers already holding CE marking or FDA clearance. The TGA accepts international conformity assessment certificates from recognised bodies, reducing duplicative testing for compliant manufacturers. However, Australian-specific labelling, adverse event reporting, and Sponsor obligations still require dedicated local expertise.
Mandatory Australian Sponsor Requirement
Every medical device supplied in Australia must have an Australian Sponsor who is resident or incorporated in Australia and who accepts full legal responsibility for the device under the Therapeutic Goods Act 1989. Overseas manufacturers cannot self-sponsor, making Legal Representation an essential first step for any international company seeking market access. Failure to appoint a valid Sponsor before supply constitutes a serious offence under Australian law.
Growing Demand Across Aged Care and Digital Health
Australia's ageing population and expanding private health insurance sector are driving strong demand for orthopaedic implants, cardiovascular devices, and remote patient monitoring solutions. The Australian Government's investment in digital health infrastructure and the expansion of telehealth following COVID-19 has accelerated adoption of connected medical devices. Manufacturers in these segments face both significant opportunity and heightened TGA scrutiny around software as a medical device regulations.
Software as a Medical Device Regulatory Evolution
The TGA has introduced updated guidance on Software as a Medical Device (SaMD) aligned with the IMDRF framework, creating new classification and registration obligations for digital health products. Companies offering AI-powered diagnostics, clinical decision support software, or app-based monitoring tools must now navigate a more complex ARTG pathway than previously required. Taevas Global has specific expertise in SaMD classification and helps manufacturers determine whether their software product requires ARTG inclusion.
What's Included
Everything in Your Engagement
Every Taevas Global Legal Representation engagement for Medical Devices in Australia includes the following eight core deliverables, ensuring complete regulatory coverage from day one through to ongoing market presence.
Regulatory Assessment Report
A written analysis of your device classification, applicable ARTG pathway, conformity assessment requirements, and documentation gaps specific to Australian TGA obligations.
Australian Sponsor Deed and TGA Registration
Formal execution of the Sponsor appointment deed and update of TGA records to designate Taevas Global as your lawful Australian Sponsor for all nominated devices.
ARTG Application Package
Complete preparation and lodgement of your ARTG inclusion application via the TGA's Therapeutic Goods Business Services portal, including all supporting technical documentation.
Essential Principles Compliance Checklist
A completed and signed Essential Principles checklist mapping your device's technical documentation to each applicable safety and performance requirement under Australian regulations.
Labelling and IFU Compliance Review
A detailed review of all product labelling, packaging, and instructions for use against TGA labelling schedule requirements, with written recommendations for any required amendments.
Post-Market Compliance Calendar
A tailored 12-month compliance calendar covering all mandatory TGA reporting deadlines, ARTG renewal dates, and post-market surveillance obligations for your device portfolio.
Adverse Event Reporting and Vigilance Management
Ongoing management of mandatory adverse event and incident reporting to the TGA, including preparation of reports within regulatory timeframes and coordination of any required field safety corrective actions.
Distributor and Channel Partner Introduction
Facilitated introductions to qualified Australian medical device distributors and channel partners, including a brief due diligence summary to support your commercial decision-making.
Who This Is For
Built for These Situations
Market Entry
Overseas Manufacturer Entering Australia for the First Time
You have an established medical device with CE marking or FDA clearance and are ready to access the Australian market but have no local entity, no Australian Sponsor, and limited knowledge of TGA processes. You need a trusted partner who can act as your legal representative, manage the ARTG application, and ensure you are compliant from day one of supply. Speed to market and regulatory certainty are your top priorities.
Outcome
Achieve ARTG inclusion and lawful market access in Australia within your commercial timeline, with full Sponsor obligations covered by Taevas Global.
Next Steps
After Legal Representation, Most Clients Move To
FAQ
Common Questions
Get Started
Ready to Enter the Australia Market?
Taevas Global provides end-to-end Legal Representation for Medical Devices companies entering Australia, from Australian Sponsor appointment through to ARTG inclusion and ongoing TGA compliance. Speak with our regulatory team today to get a clear picture of your pathway to market.
Australian Sponsor appointment handled within days, not months
Dedicated TGA regulatory advisor with medical device specialisation
Full ARTG application management from documentation to inclusion
Ongoing post-market compliance so your supply chain is never at risk